§ BIOTECHNOLOGY
USD · BiotechnologyARQT
ARCUTIS BIOTHERAPEUTICS INC
USDSector · BiotechnologyBeta · 1.65
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
142 increased/new, 103 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 18.77 | EPS (TTM) | -0.13 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 12.3M | 7.4% | +3% |
| Frazier Life Sciences Management, L.P. | 9.9M | 6.0% | ±0% |
| BlackRock, Inc. | 9.2M | 0.0% | +1% |
| Rubric Capital Management LP | 8.3M | 2.1% | ±0% |
| State Street | 6.3M | 0.0% | +15% |
| Polar Capital Holdings Plc | 5.7M | 0.5% | +2% |
◇ AC INTELLIGENCE
Top institutional owners for ARQT as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER95.4% · 0 holders
OTHER2.5% · 187 holders
DEALER / BANK0.7% · 26 holders
QUALITY / COMPOUNDER0.6% · 21 holders
PASSIVE / INDEX0.5% · 9 holders
SYSTEMATIC / QUANT0.2% · 8 holders
INCOME / DEFENSIVE0.1% · 15 holders
ACTIVIST0.1% · 1 holder
GROWTH / MOMENTUM0.0% · 1 holder
TACTICAL / MACRO0.0% · 2 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for ARQT in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention ARQT yet.